This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Masatoshi Hagiwara, Other. Active years: 2009-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
2 out of 834,601 Years Active: 2009-2014
Title: Innovations of Takeshi Fukuhara in Antiviral Research
Introduction
Takeshi Fukuhara is a prominent inventor based in Tokyo, Japan, known for his significant contributions to antiviral research. He holds three patents that focus on methods for controlling SR protein phosphorylation and developing antiviral agents. His work addresses the urgent need for effective treatments against emerging viruses.
Latest Patents
Fukuhara's latest patents include innovative methods for controlling SR protein phosphorylation. These patents describe antiviral agents that reduce or inhibit the activity of SR proteins. Specifically, they include agents that enhance the dephosphorylation of SR proteins and those that inhibit the proteins responsible for phosphorylating SR proteins. Additionally, the patents cover agents that inhibit the expression of SR proteins and those that activate proteins that antagonize SR proteins. Furthermore, the inventions provide compounds that inhibit SR protein kinases (SRPKs), which play a crucial role in phosphorylating SR proteins. These compounds not only inhibit the activity of SR proteins but also exhibit antiviral properties, making them valuable in combating various new viruses, including SARS.
Career Highlights
Throughout his career, Fukuhara has made notable advancements in the field of antiviral research. His innovative approaches have led to the development of long-lasting broad-spectrum antiviral agents that are applicable to new viruses. His work is critical in the ongoing fight against viral infections and highlights the importance of research in this area.
Collaborations
Fukuhara has collaborated with several notable individuals in his field, including Masatoshi Hagiwara and Masaaki Suzuki. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Takeshi Fukuhara's contributions to antiviral research through his innovative patents demonstrate his commitment to addressing global health challenges. His work in controlling SR protein activity is paving the way for new antiviral treatments that could significantly impact public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile